comprehensive -WSS

comprehensive

author：hotspot 2025-10-02 20:52:27 - browse：8

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Study gives hint on South Asians’ higher risk of cardiovascular disease

hotspot

WSS

David Liu startup to focus on CRISPR delivery

Congress might make insulin pumps more accessible to the blind

Long Covid research funding gets a major boost from NIH

Why the drug industry's warnings on the IRA's impact fall short

Tome Biosciences co

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Long Covid research funding gets a major boost from NIH

Medical records are filled with copy

Transgender sports debate: Physicians say bans are health issue

DIEP, the 'gold standard' of breast reconstruction, is under threat

Congress might make insulin pumps more accessible to the blind

Guidelines to prevent youth baseball injuries need more muscle

Eli Lilly reports tirzepatide MASH success during Q4 earnings

In Memoriam: Notable people who died in 2023

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Wikipedia

STAT Boddities: What happens to the brain when we get scared?

Bernie Sanders gets little from pharma CEOs on drug prices

People with substance use disorder deserve online privacy

Study gives hint on South Asians’ higher risk of cardiovascular disease

'A game

People with substance use disorder deserve online privacy

leisure time

explore

hotspot

hotspot